Back
Alnylam Pharmaceuticals Vs. Dave Industry Stock Comparison
Sell
30
ALNY
Alnylam Pharmaceuticals
Last Price:
253.13
Seasonality Move:
7.55%
Buy
99
DAVE
Dave
Last Price:
99.01
Seasonality Move:
73.86%
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $253.07. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $98.68. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $253.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.
DAVE Stock Price Chart
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.04 | Sell |
| Relative Strength Index (14 RSI): | 44.15 | Sell |
| Chaikin Money Flow: | 152237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (246.3 - 278.6) | Sell |
| Bollinger Bands (100): | (248.75 - 281.71) | Sell |
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.57 | Buy |
| Relative Strength Index (14 RSI): | 79.73 | Buy |
| Chaikin Money Flow: | 61535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.26 - 85.52) | Buy |
| Bollinger Bands (100): | (28.73 - 60.47) | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 248.24 | Buy |
| 20-day SMA: | 257.83 | Sell |
| 50-day SMA: | 271.05 | Sell |
| 200-day SMA: | 213.33 | Buy |
| 8-day EMA: | 251.28 | Buy |
| 20-day EMA: | 257.22 | Sell |
| 50-day EMA: | 263.45 | Sell |
| 200-day EMA: | 231.88 | Buy |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 86.38 | Buy |
| 20-day SMA: | 70.08 | Buy |
| 50-day SMA: | 53.04 | Buy |
| 200-day SMA: | 40.89 | Buy |
| 8-day EMA: | 87 | Buy |
| 20-day EMA: | 74.22 | Buy |
| 50-day EMA: | 58.81 | Buy |
| 200-day EMA: | 40.81 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.39 per share.
Alnylam Pharmaceuticals Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dave Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||